Table 5 Correlation of miR-92b-3p expression with clinicopathological features (\(\overline{\mathrm{x}}\pm \mathrm{s }\))
From: Expression levels and clinical values of miR-92b-3p in breast cancer
Number of cases | miR-92b-3p | t | P | |
|---|---|---|---|---|
Age (years) | 0.48 | 0.63 | ||
< 50 | 52 | 1.56 ± 0.35 | ||
≥ 50 | 60 | 1.59 ± 0.31 | ||
Tumour size (cm) | 6.21 | 0.00 | ||
< 2 | 43 | 1.37 ± 0.32 | ||
≥ 2 | 69 | 1.72 ± 0.27 | ||
Degree of differentiation | 5.88 | 0.00 | ||
Moderately + highly differentiated | 44 | 1.38 ± 0.34 | ||
Lowly differentiated | 68 | 1.74 ± 0.30 | ||
TNM staging | 6.47 | 0.00 | ||
I-II | 55 | 1.41 ± 0.42 | ||
III | 57 | 1.86 ± 0.31 | ||
Menopause | 0.89 | 0.37 | ||
Yes | 41 | 1.55 ± 0.38 | ||
No | 71 | 1.62 ± 0.41 | ||
Lymphatic metastasis | 4.63 | 0.00 | ||
No | 40 | 1.40 ± 0.37 | ||
Yes | 72 | 1.75 ± 0.39 |